| Application number | Title of the application | Filing Date | Status |
|---|
| 07/931339 | MONOCLONAL ANTIBODIES AND VACCINE DEVELOPMENT DIRECTED TO HUMAN CANCER-ASSOCIATED ANTIGENS BY IMMUNIZATION WITH ANIMAL AND HUMAN MUCIN AND WITH SYNTHETIC CARBOHYDRATE-CARRIER CONJUGATES | Aug 17, 1992 | Abandoned |
| 07/926666 | HLA BINDING PEPTIDES AND THEIR USES | Aug 6, 1992 | Abandoned |
Array
(
[id] => 3588229
[patent_doc_number] => 05585264
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-17
[patent_title] => 'Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides'
[patent_app_type] => 1
[patent_app_number] => 7/921849
[patent_app_country] => US
[patent_app_date] => 1992-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 63
[patent_no_of_words] => 37167
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/585/05585264.pdf
[firstpage_image] =>[orig_patent_app_number] => 921849
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/921849 | Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides | Jul 28, 1992 | Issued |
| 07/914642 | ANTI-IDIOTYPE VACCINATION AGAINST DISEASES RESULTING FROM PATHOGENIC RESPONSES BY SPECIFIC T CELL POPULATIONS | Jul 15, 1992 | Abandoned |
| 07/914177 | NOVEL ANTIGENS AND METHODS THEREFOR | Jul 13, 1992 | Abandoned |
Array
(
[id] => 4077166
[patent_doc_number] => 06054126
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-25
[patent_title] => 'Cloning and expression of host-protective immunogens of IBDV'
[patent_app_type] => 1
[patent_app_number] => 7/902846
[patent_app_country] => US
[patent_app_date] => 1992-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 16
[patent_no_of_words] => 13069
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/054/06054126.pdf
[firstpage_image] =>[orig_patent_app_number] => 902846
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/902846 | Cloning and expression of host-protective immunogens of IBDV | Jun 22, 1992 | Issued |
| 07/903069 | MULTIMERIC FORMS OF HUMAN RHINOVIRUS RECEPTOR PROTEIN | Jun 21, 1992 | Abandoned |
Array
(
[id] => 2986226
[patent_doc_number] => 05250661
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-10-05
[patent_title] => 'Established cell line'
[patent_app_type] => 1
[patent_app_number] => 7/878451
[patent_app_country] => US
[patent_app_date] => 1992-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7453
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/250/05250661.pdf
[firstpage_image] =>[orig_patent_app_number] => 878451
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/878451 | Established cell line | May 4, 1992 | Issued |
| 07/873663 | IMMUNOGENS AND THE USE THEREOF FOR OBTAINING ANTIBODIES AGAINST HBA1C | Apr 22, 1992 | Abandoned |
Array
(
[id] => 3457953
[patent_doc_number] => 05468481
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-11-21
[patent_title] => 'MHC class II-peptide conjugates useful in ameliorating autoimmunity'
[patent_app_type] => 1
[patent_app_number] => 7/869293
[patent_app_country] => US
[patent_app_date] => 1992-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 35
[patent_no_of_words] => 20609
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/468/05468481.pdf
[firstpage_image] =>[orig_patent_app_number] => 869293
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/869293 | MHC class II-peptide conjugates useful in ameliorating autoimmunity | Apr 13, 1992 | Issued |
| 07/835948 | TREATMENT OF CHRONIC INFLAMMATORY CONDITIONS | Apr 12, 1992 | Abandoned |
Array
(
[id] => 3003231
[patent_doc_number] => 05330753
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-07-19
[patent_title] => 'Cholera vaccines'
[patent_app_type] => 1
[patent_app_number] => 7/855809
[patent_app_country] => US
[patent_app_date] => 1992-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5380
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/330/05330753.pdf
[firstpage_image] =>[orig_patent_app_number] => 855809
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/855809 | Cholera vaccines | Mar 22, 1992 | Issued |
Array
(
[id] => 3023880
[patent_doc_number] => 05348740
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-09-20
[patent_title] => 'Antigenic polypeptides of Taenia ovis'
[patent_app_type] => 1
[patent_app_number] => 7/851112
[patent_app_country] => US
[patent_app_date] => 1992-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8838
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/348/05348740.pdf
[firstpage_image] =>[orig_patent_app_number] => 851112
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/851112 | Antigenic polypeptides of Taenia ovis | Mar 15, 1992 | Issued |
Array
(
[id] => 4050200
[patent_doc_number] => 05869608
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-09
[patent_title] => 'Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis'
[patent_app_type] => 1
[patent_app_number] => 7/853359
[patent_app_country] => US
[patent_app_date] => 1992-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 5854
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/869/05869608.pdf
[firstpage_image] =>[orig_patent_app_number] => 853359
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/853359 | Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis | Mar 15, 1992 | Issued |
| 07/850802 | ANTIBODIES SPECIFIC FOR ELAM-1 AND THE USE THEREOF | Mar 12, 1992 | Abandoned |
| 07/848517 | DIAGNOSIS AND TREATMENT OF INSULIN DEPENDENT DIABETES MELLITUS | Mar 8, 1992 | Abandoned |
Array
(
[id] => 3662803
[patent_doc_number] => 05599543
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-04
[patent_title] => 'Immunogenic four amino acid epitope against Plasmodium vivax'
[patent_app_type] => 1
[patent_app_number] => 7/848636
[patent_app_country] => US
[patent_app_date] => 1992-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6773
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/599/05599543.pdf
[firstpage_image] =>[orig_patent_app_number] => 848636
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/848636 | Immunogenic four amino acid epitope against Plasmodium vivax | Mar 8, 1992 | Issued |
Array
(
[id] => 4001390
[patent_doc_number] => 05888512
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-30
[patent_title] => 'Lymphocyte activity regulation by HLA peptides'
[patent_app_type] => 1
[patent_app_number] => 7/844716
[patent_app_country] => US
[patent_app_date] => 1992-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 11761
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/888/05888512.pdf
[firstpage_image] =>[orig_patent_app_number] => 844716
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/844716 | Lymphocyte activity regulation by HLA peptides | Mar 1, 1992 | Issued |
Array
(
[id] => 3096921
[patent_doc_number] => 05298605
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-03-29
[patent_title] => 'Antibodies to islet amyloid polypeptide (IAPP) and subunits thereof'
[patent_app_type] => 1
[patent_app_number] => 7/838043
[patent_app_country] => US
[patent_app_date] => 1992-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5245
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/298/05298605.pdf
[firstpage_image] =>[orig_patent_app_number] => 838043
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/838043 | Antibodies to islet amyloid polypeptide (IAPP) and subunits thereof | Feb 18, 1992 | Issued |
| 07/832854 | METHODS OF TREATING ANGIOGENESIS-INDUCED DISEASES AND PHARMACEUTICAL COMPOSITIONS THEREOF | Feb 6, 1992 | Abandoned |
